Title of article :
COVID-19 and Substance Use Disorders: Recommendations to a Comprehensive Healthcare Response. An International Society of Addiction Medicine (ISAM) Practice and Policy Interest Group Position Paper
Author/Authors :
Farhoudian ، Ali Department of Psychiatry - Tehran University of Medical Sciences , Baldacchino ، Alexander Division of Population and Behavioral Sciences - St Andrews University Medical School - University of St Andrews , Clark ، Nicolas North Richmond Community Health , Gerra ، Gilberto Division for Operations - United Nations Office on Drugs and Crime, Drug Prevention and Health Branch , Ekhtiari ، Hamed Laureate Institute for Brain Research , Dom ، Geert Collaborative Antwerp Psychiatric Research Institute - University of Antwerp , Mokri ، Azarakhsh Department of Psychiatry - Tehran University of Medical Sciences , Sadeghi ، Mandana Aftab Mehrvarzi Substance Abuse Treatment Center , Nematollahi ، Pardis Cancer Prevention Research Center - Isfahan University of Medical Sciences , Demasi ، Maryanne North Richmond Community Health , Schütz ، Christian G. Department of Psychiatry - University of British Columbia , Hashemian ، Mohammadreza Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases - Shahid Beheshti University of Medical Sciences , Tabarsi ، Payam Clinical Tuberculosis and Epidemiology Research Center, National Research Institute for Tuberculosis and Lung Disease (NRITLD) - Shahid Beheshti University of Medical Sciences , Galea-singer ، Susanna Institute for Innovation and Improvement, Centre for Addictions Research - University of Auckland , Carrà ، Giuseppe Department of Medicine and Surgery, Section of Psychiatry - University of Milan Bicocca , Clausen ، Thomas Norwegian Centre for Addiction Research (SERAF) - University of Oslo , Kouimtsidis ، Christos Ministry of Health , Tolomeo ، Serenella Department of Psychology - National University of Singapore (NUS) , Radfar ، Ramin Substance Abuse and Dependence Research Center - University of Social Welfare and Rehabilitation Sciences , Razaghi ، Emran Mohammad Department of Psychiatry - Tehran University of Medical Sciences
Abstract :
Coronavirus Disease 2019 (COVID-19) is escalating all over the world and has higher morbidities and mortalities in certain vulnerable populations. People Who Use Drugs (PWUD) are a marginalized and stigmatized group with weaker immunity responses, vulnerability to stress, poor health conditions, high-risk behaviors, and lower access to health care services. These conditions put them at a higher risk of COVID-19 infection and its complications. In this paper, an international group of experts on addiction medicine, infectious diseases, and disaster psychiatry explore the possible raised concerns in this issue and provide recommendations to manage the comorbidity of COVID-19 and Substance Use Disorder (SUD).
Keywords :
Coronavirus , Coronavirus Disease 2019 (COVID , 19) , Pandemic , Public health , Substance use disorder , Addiction medicine , Harm reduction , Policy , Methadone , Opioid substitution therapy
Journal title :
Basic and Clinical Neuroscience
